IonSource Daily Links to 
Mass Spectrometry, Biotechnology and Pharmaceutical  Industry News

 

IonSource Home | Disclaimer

Note: News stories may be minutes or several days old and should not be used for investment purposes.

-

-

-
5/13/13 FDA Accepts Biogen Idec’s Biologics License Application for First Long-Lasting Factor VIII Therapy for Hemophilia A
   
  Patent Protection for TAL Effector Technology Enables Licensing Path for Life Technologies Customers
   
   Agilent Technologies Introduces AdvanceBio Peptide Mapping Columns
   
5/10/13 Novartis drug Ilaris® approved by FDA to treat active systemic juvenile idiopathic arthritis, a serious form of childhood arthritis
   
  GSK: BREO™ ELLIPTA™ gains US approval for the treatment of COPD
   
  Lilly Announces Enzastaurin Phase III Study Did Not Meet Primary Endpoint in Diffuse Large B-Cell Lymphoma
   
5/09/13 GSK and Save the Children form unique partnership to save the lives of one million children An ambitious new partnership to save the lives of a million of the poorest children in the world has been launched by GSK and Save the Children
   
  GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world’s poorest countries GlaxoSmithKline (GSK) today announced a new commitment to the GAVI Alliance to supply its cervical cancer vaccine as part of a new long term programme to help protect girls against cervical cancer in the world’s poorest countries.

 

   
  GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], Merck’s HPV Vaccine, Available to Developing Countries through UNICEF Tender
   
  Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
   
5/08/13 Merck Announces FDA Acceptance of Biologics License Application for Investigational Ragweed Pollen Sublingual Allergy Immunotherapy Tablet
   
5/07/13 Millenium: Meta-Analysis of VELCADE® (bortezomib)-Based Induction Therapy Followed by Stem-Cell Transplantation Showed Significantly Greater Response and Longer Progression-Free and Overall Survival in Patients with Multiple Myeloma
   
  Amgen Announces Top-Line Results of Vectibix® (panitumumab) Phase 3 Head-to-Head Study Against Erbitux® (cetuximab) in Metastatic Colorectal Cancer
   
  GSK gives update on plans to share detailed clinical trial data as part of its commitment to transparency GlaxoSmithKline (GSK) today announced progress on its commitment to share more detailed data from its clinical trials.

 

   
5/06/13 BMS: Sub-Group Analysis Shows Investigational Metreleptin Treatment Demonstrated Reductions in HbA1c, Triglycerides and Liver Function Tests in Pediatric Patients with Lipodystrophy During a 12-Month Period
   
5/03/13 FDA Approves Merck’s LIPTRUZET™ (ezetimibe and atorvastatin), a New Product That Can Help Powerfully Lower LDL Cholesterol
   
  Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA® (efavirenz) in HIV-1 Infected Pediatric Patients
   
5/02/13 Gilead Reports Interim Data From Phase 2 LONESTAR Study
   
  Regulatory update: Trametinib US PDUFA date extended to 3 September 2013
   
5/01/13 Merck Announces New $15 Billion Share Repurchase Program
   
  GSK announces regulatory submission for umeclidinium monotherapy in US
   
  GSK today announced that the US Prescription Drug User Fee Act (PDUFA) goal date for trametinib, its MEK inhibitor, has been extended by 3 months to 3 September 2013.
   
4/30/13 GlaxoSmithKline plc today announced the submission of a regulatory application in the US for the investigational once-daily medicine, umeclidinium bromide (UMEC), for patients with chronic obstructive pulmonary disease (COPD).
   
4/29/13 Bruker Expands Capabilities of MALDI Biotyper Platform for Microbiology
   
  Merck Wins FOSAMAX® (alendronate sodium) Federal Bellwether Trial Involving Atypical Femur Fracture Claims
   
  Gilead Receives Complete Response Letters from U.S. Food and Drug Administration for Elvitegravir and Cobicistat
   
  Incyte Achieves $25 Million Milestone as c-MET Inhibitor INC280 Advances Into Phase II Development
   
4/26/13 Expanded Control of Shimadzu LC Systems for Empower(TM) Software - Waters Empower(TM) Software Now Controls Shimadzu Nexera X2 Series Products
   
  Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
   
4/25/13 Shimadzu's novel Imaging Mass Microscope, iMScope, enables optical microscopic observing samples to be mass spectrometric analyzed directly in the one instrument. - Application in disease biomarker research and biological function studies
   
  Roche Turkey visits hospitals to hand presents to children with cancer
   
4/23/13 Bayer CropScience and KeyGene enter into research agreement to develop improved crop varieties – initial focus on wheat more
   
  Data from Phase 3 Studies of Gilead’s Sofosbuvir for Hepatitis C
   
  Novartis once-daily QVA149 shows superior efficacy in reducing exacerbations, improving lung function and quality of life in COPD patients
   
4/22/13 Merck Enters Agreement with Bristol-Myers Squibb to Conduct a Phase II Clinical Trial Evaluating Combination of Investigational Oral Candidates MK-5172 and Daclatasvir for Chronic Hepatitis C
   
4/19/13 Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma
   
  Alcon announces FDA approval of Simbrinza(TM) Suspension, a new beta blocker-free, fixed-combination therapy for glaucoma patients
   
4/18/13 Bruker and the Genome British Columbia Proteomics Centre at the University of Victoria Announce Collaboration on Development of High Throughput iMALDI Assays
   
  AB SCIEX and LECO Partner to Offer Combined Solutions for GC/MS and LC/MS to Metabolomics Researchers
   
  Eurofins Collaborates with AB SCIEX and Phenomenex to Improve Analysis of Animal Feed
   
  Abbott Announces FDA Approval and U.S. Launch of the TECNIS® Toric Intraocular Lens for Cataract Patients
   
4/17/13 GSK: FDA Advisory Committee recommends approval of BREO(TM) ELLIPTA(TM) for the treatment of COPD
   
  Lilly Acquires Novel Tau Tangle Diagnostic Program to Bolster Alzheimer's Disease Research and Development
   
4/16/13 Bayer CropScience and Monsanto Enter into Cross-Licensing Agreements for Next-Generation and Enabling Technologies
   
  Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes
   
4/16/13 Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
   
  Merck Opens New Manufacturing Facility in Hangzhou, China
   
  Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes
   
4/15/13 Thermo Fisher Scientific to Acquire Life Technologies Corporation
   
  Agilent Technologies Introduces Enhanced NMR Data-Acquisition Software, Providing Optimal Speed and Spectral Quality with Minimal Effort
   
4/11/13 Life Technologies Launches New Bioinformatics Software Platform Enabling Bio-Design and Gene Synthesis from Next Generation Sequencing Data
   
  Roche Group posts strong sales growth in the first quarter
   
4/10/13 Pfizer Palbociclib (PD-0332991) Receives Food And Drug Administration Breakthrough Therapy Designation For Potential Treatment Of Patients With Breast Cancer
   
  Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient
   
  Merck Announces FDA Acceptance of New Drug Application for an Investigational Tablet Formulation of the Antifungal NOXAFIL® (posaconazole)
   
4/08/13 Gilead Submits New Drug Application to U.S. FDA for Sofosbuvir for the Treatment of Hepatitis C
   
4/07/13 Meta-Analysis of VELCADE® (bortezomib)-Based Induction Therapy Followed by Stem-Cell Transplantation Showed Significantly Greater Response and Longer Progression-Free and Overall Survival in Patients with Multiple Myeloma
   
4/05/13 Takeda and Millennium Announce Approval of ADCETRIS® (Brentuximab Vedotin) in Switzerland
   
4/04/13 The Lancet Publishes SELECT Study Evaluating Efficacy and Safety of Daclizumab HYP in Multiple Sclerosis
   
  Roche launches new test for diagnosis and monitoring of thyroid cancer
   
4/03/13 Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 24, 2013
   
  GlaxoSmithKline announces start of phase III study of Benlysta® (belimumab ) in patients with vasculitis
   
  GSK announces first four-strain seasonal influenza vaccine granted marketing authorisation in Germany and the UK GlaxoSmithKline plc has announced the marketing authorization of its quadrivalent (four-strain) influenza vaccine in Germany and the UK.
   
4/02/13 Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations
   
  Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI®
   
  Potential Lilly Investment Would Further Expand Indianapolis Insulin Manufacturing Operations
   
   

Company News

On-Line Magazines Hot News Sites
Abbott
Agilent
Amgen
AB SCIEX
Bayer
Biogen_Idec
Bruker
BMS Company
DepoMed
Vermillion
Eli Lilly
Genentech
Geron
Gilead
GSK
Incyte Gen.
Life Technologies
Leap Tech.
Nordion
Maxygen

Merck
Millennium
Myriad
Nektar
Novartis
Pfizer
Roche
Sangamo
Shimadzu
ThermoElectron
LCGC Magazine
Drug Discovery and Development Magazine
New Scientist

Proteomic Company News Links
Check out the Proteomics page at IonSource 

BioWire2K
Coranate
FierceBiotech
GenomeWeb
GE News of the Day
Moreover
ScienceNews On-Line
The Seattle Times
SF Gate Technology News

 

Archive of old news 

home | disclaimer
Copyright © 2001-2011  IonSource, LLC  All rights reserved. 
Last updated:  Monday, May 13, 2013 12:23:31 PM

Hit Counter